ALGN vs. DHR: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at ALGN and DHR, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | ALGN | DHR |
|---|---|---|
| Company Name | Align Technology, Inc. | Danaher Corporation |
| Country | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Health Care Equipment & Supplies | Life Sciences Tools & Services |
| Market Capitalization | 9.53 billion USD | 151.60 billion USD |
| Exchange | NasdaqGS | NYSE |
| Listing Date | January 30, 2001 | December 29, 1978 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of ALGN and DHR by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | ALGN | DHR |
|---|---|---|
| 5-Day Price Return | 5.02% | 6.78% |
| 13-Week Price Return | -32.16% | 6.05% |
| 26-Week Price Return | -16.81% | 5.65% |
| 52-Week Price Return | -44.51% | -21.74% |
| Month-to-Date Return | 5.02% | 6.78% |
| Year-to-Date Return | -36.93% | -7.77% |
| 10-Day Avg. Volume | 1.23M | 6.05M |
| 3-Month Avg. Volume | 1.38M | 4.12M |
| 3-Month Volatility | 80.58% | 33.41% |
| Beta | 1.85 | 0.90 |
Profitability
Return on Equity (TTM)
ALGN
11.29%
Health Care Equipment & Supplies Industry
- Max
- 29.93%
- Q3
- 16.99%
- Median
- 9.28%
- Q1
- 5.10%
- Min
- -12.52%
ALGN’s Return on Equity of 11.29% is on par with the norm for the Health Care Equipment & Supplies industry, indicating its profitability relative to shareholder equity is typical for the sector.
DHR
6.69%
Life Sciences Tools & Services Industry
- Max
- 19.96%
- Q3
- 11.51%
- Median
- 6.47%
- Q1
- 3.86%
- Min
- -6.95%
DHR’s Return on Equity of 6.69% is on par with the norm for the Life Sciences Tools & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
ALGN
11.04%
Health Care Equipment & Supplies Industry
- Max
- 24.41%
- Q3
- 13.71%
- Median
- 10.08%
- Q1
- 5.96%
- Min
- -5.58%
ALGN’s Net Profit Margin of 11.04% is aligned with the median group of its peers in the Health Care Equipment & Supplies industry. This indicates its ability to convert revenue into profit is typical for the sector.
DHR
14.21%
Life Sciences Tools & Services Industry
- Max
- 32.18%
- Q3
- 18.30%
- Median
- 10.19%
- Q1
- 4.20%
- Min
- -2.05%
DHR’s Net Profit Margin of 14.21% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
ALGN
15.15%
Health Care Equipment & Supplies Industry
- Max
- 31.09%
- Q3
- 18.11%
- Median
- 15.07%
- Q1
- 8.48%
- Min
- -0.28%
ALGN’s Operating Profit Margin of 15.15% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.
DHR
18.43%
Life Sciences Tools & Services Industry
- Max
- 38.39%
- Q3
- 21.40%
- Median
- 13.57%
- Q1
- 8.38%
- Min
- -3.51%
DHR’s Operating Profit Margin of 18.43% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | ALGN | DHR |
|---|---|---|
| Return on Equity (TTM) | 11.29% | 6.69% |
| Return on Assets (TTM) | 7.03% | 4.28% |
| Net Profit Margin (TTM) | 11.04% | 14.21% |
| Operating Profit Margin (TTM) | 15.15% | 18.43% |
| Gross Profit Margin (TTM) | 69.84% | 59.72% |
Financial Strength
Current Ratio (MRQ)
ALGN
1.23
Health Care Equipment & Supplies Industry
- Max
- 5.19
- Q3
- 3.00
- Median
- 2.13
- Q1
- 1.44
- Min
- 0.86
ALGN’s Current Ratio of 1.23 falls into the lower quartile for the Health Care Equipment & Supplies industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
DHR
1.62
Life Sciences Tools & Services Industry
- Max
- 3.46
- Q3
- 2.78
- Median
- 1.91
- Q1
- 1.53
- Min
- 0.43
DHR’s Current Ratio of 1.62 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
ALGN
0.00
Health Care Equipment & Supplies Industry
- Max
- 1.61
- Q3
- 0.76
- Median
- 0.45
- Q1
- 0.14
- Min
- 0.00
Falling into the lower quartile for the Health Care Equipment & Supplies industry, ALGN’s Debt-to-Equity Ratio of 0.00 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.
DHR
0.33
Life Sciences Tools & Services Industry
- Max
- 1.35
- Q3
- 0.74
- Median
- 0.41
- Q1
- 0.18
- Min
- 0.00
DHR’s Debt-to-Equity Ratio of 0.33 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
ALGN
38.91
Health Care Equipment & Supplies Industry
- Max
- 56.35
- Q3
- 25.56
- Median
- 9.60
- Q1
- 3.78
- Min
- -26.49
ALGN’s Interest Coverage Ratio of 38.91 is in the upper quartile for the Health Care Equipment & Supplies industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.
DHR
22.31
Life Sciences Tools & Services Industry
- Max
- 45.00
- Q3
- 27.84
- Median
- 7.16
- Q1
- 2.12
- Min
- -14.08
DHR’s Interest Coverage Ratio of 22.31 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | ALGN | DHR |
|---|---|---|
| Current Ratio (MRQ) | 1.23 | 1.62 |
| Quick Ratio (MRQ) | 1.06 | 1.10 |
| Debt-to-Equity Ratio (MRQ) | 0.00 | 0.33 |
| Interest Coverage Ratio (TTM) | 38.91 | 22.31 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
ALGN
0.00%
Health Care Equipment & Supplies Industry
- Max
- 4.15%
- Q3
- 1.76%
- Median
- 0.79%
- Q1
- 0.00%
- Min
- 0.00%
ALGN currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
DHR
0.53%
Life Sciences Tools & Services Industry
- Max
- 1.41%
- Q3
- 0.65%
- Median
- 0.35%
- Q1
- 0.00%
- Min
- 0.00%
DHR’s Dividend Yield of 0.53% is consistent with its peers in the Life Sciences Tools & Services industry, providing a dividend return that is standard for its sector.
Dividend Payout Ratio (TTM)
ALGN
0.00%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 66.60%
- Median
- 27.49%
- Q1
- 0.00%
- Min
- 0.00%
ALGN has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
DHR
23.85%
Life Sciences Tools & Services Industry
- Max
- 113.14%
- Q3
- 61.34%
- Median
- 17.74%
- Q1
- 0.00%
- Min
- 0.00%
DHR’s Dividend Payout Ratio of 23.85% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
| Symbol | ALGN | DHR |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.53% |
| Dividend Payout Ratio (TTM) | 0.00% | 23.85% |
Valuation
Price-to-Earnings Ratio (TTM)
ALGN
21.61
Health Care Equipment & Supplies Industry
- Max
- 67.29
- Q3
- 47.01
- Median
- 30.94
- Q1
- 23.91
- Min
- 10.79
In the lower quartile for the Health Care Equipment & Supplies industry, ALGN’s P/E Ratio of 21.61 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.
DHR
44.66
Life Sciences Tools & Services Industry
- Max
- 75.35
- Q3
- 51.00
- Median
- 32.93
- Q1
- 25.27
- Min
- 1.43
DHR’s P/E Ratio of 44.66 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
ALGN
2.38
Health Care Equipment & Supplies Industry
- Max
- 9.49
- Q3
- 5.41
- Median
- 2.86
- Q1
- 2.07
- Min
- 0.74
ALGN’s P/S Ratio of 2.38 aligns with the market consensus for the Health Care Equipment & Supplies industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
DHR
6.35
Life Sciences Tools & Services Industry
- Max
- 10.49
- Q3
- 6.43
- Median
- 4.66
- Q1
- 2.88
- Min
- 1.08
DHR’s P/S Ratio of 6.35 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
ALGN
3.51
Health Care Equipment & Supplies Industry
- Max
- 10.85
- Q3
- 6.56
- Median
- 3.53
- Q1
- 2.36
- Min
- 0.71
ALGN’s P/B Ratio of 3.51 is within the conventional range for the Health Care Equipment & Supplies industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
DHR
2.72
Life Sciences Tools & Services Industry
- Max
- 6.69
- Q3
- 5.00
- Median
- 3.46
- Q1
- 2.38
- Min
- 0.93
DHR’s P/B Ratio of 2.72 is within the conventional range for the Life Sciences Tools & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | ALGN | DHR |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 21.61 | 44.66 |
| Price-to-Sales Ratio (TTM) | 2.38 | 6.35 |
| Price-to-Book Ratio (MRQ) | 3.51 | 2.72 |
| Price-to-Free Cash Flow Ratio (TTM) | 14.97 | 31.35 |